Clinical Profiles, Occurrence, and Management of Adolescent Patients with HAIR-AN Syndrome by Omar, Hatim A. et al.
University of Kentucky
UKnowledge
Pediatrics Faculty Publications Pediatrics
7-8-2004
Clinical Profiles, Occurrence, and Management of
Adolescent Patients with HAIR-AN Syndrome
Hatim A. Omar
University of Kentucky, hatim.omar@uky.edu
Stephanie Logsdon
University of Kentucky
Jessica Richards
University of Kentucky
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/pediatrics_facpub
Part of the Pediatrics Commons
This Article is brought to you for free and open access by the Pediatrics at UKnowledge. It has been accepted for inclusion in Pediatrics Faculty
Publications by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.
Repository Citation
Omar, Hatim A.; Logsdon, Stephanie; and Richards, Jessica, "Clinical Profiles, Occurrence, and Management of Adolescent Patients
with HAIR-AN Syndrome" (2004). Pediatrics Faculty Publications. 69.
https://uknowledge.uky.edu/pediatrics_facpub/69
Clinical Profiles, Occurrence, and Management of Adolescent Patients with HAIR-AN Syndrome
Notes/Citation Information
Published in The Scientific World Journal, v. 4, p. 507-511.
Copyright © 2004 Hatim A. Omar et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution and reproduction in any medium, provided that the original work is properly
cited.
Digital Object Identifier (DOI)
http://dx.doi.org/10.1100/tsw.2004.106
This article is available at UKnowledge: https://uknowledge.uky.edu/pediatrics_facpub/69
Research Article 
TheScientificWorldJOURNAL (2004) 4, 507–511 
ISSN 1537-744X; DOI 10.1100/tsw.2004.106 
 
 
Clinical Profiles, Occurrence, and Management  
of Adolescent Patients with HAIR-AN Syndrome 
Hatim A Omar*, Stephanie Logsdon, and Jessica Richards  
Section of Adolescent Medicine, Department of Pediatrics, University of Kentucky,  
Lexington, KY, 40536-0284 
E-mail: haomar2@uky.edu
Received May 10, 2004; Revised June 18, 2004; Accepted July 1, 2004; Published July 8, 2004 
The syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-
AN) is a subphenotype of the polycystic ovary syndrome. It is one of the most common 
causes of menstrual problems, hyperandrogenic symptoms, and insulin resistance 
among young women. Review of clinical data in an outpatient adolescent clinic showed 
that of the 1,002 young women (ages 10–21 years) attending the clinic over a 2-year 
period, 50 (5%) were diagnosed with HAIR-AN syndrome. Mean age of the patients was 
15.5, initial mean weight at diagnosis was 94.5 kg, and the mean BMI was 33.33 kg/m2. 
Patients were treated with a weight-stabilization and -reduction program, oral 
contraceptive pills, and in most cases metformin. Of the patients, 80% were compliant 
with the follow-up and treatment regimen, 60% maintained or reduced their weight, 95% 
had regular menstrual cycles, and in most patients, the acne and/or hirsutism were the 
same or better than at the start of treatment. We conclude that HAIR-AN syndrome is a 
common disease in young women and multifaceted, aggressive treatment appears to be 
effective in reducing the severity of symptoms and preventing further consequences. 
KEYWORDS: adolescent medicine, hyperandrogenism, insulin resistance, acanthosis 
nigricans, metformin, HAIR-AN syndrome, polycystic ovary syndrome, United States 
DOMAINS: child health and human development, medical care, behavioral psychology, clinical 
psychology, psychiatry, nursing, oncology 
 
INTRODUCTION  
The syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) has been 
known for almost 30 years[1,2,3,4]. The primary abnormality in these patients is thought to be insulin 
resistance with elevated insulin levels[1,2]. This syndrome is a unique subphenotype of the polycystic 
ovary syndrome and is seen in almost 5% of all females with hyperandrogenism[2,5]. Obesity, acne, 
hirsutism, and acanthosis nigricans usually appear on the afflicted adolescent around puberty[6]. 
Hirsutism is defined as the growth of pigmented hair on the chest, back, and lower abdomen. 
Acanthosis nigricans describes darkly pigmented, velvety areas of the skin. This manifestation of the 
syndrome is associated with insulin resistance and decreased insulin sensitivity[7]. It is still not 
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completely known how insulin resistance occurs, however, defects and genetic receptors are thought to be 
responsible in most patients[1,3,4]. When insulin levels are markedly elevated over time, they tend to 
directly stimulate the overproduction of androgens in the ovaries[3,8]. It is thought that high insulin levels 
cross-react with receptors for insulin-like growth factors leading to increased ovarian androgen 
production[2,3,8]. Approximately 5% of women with hyperandrogenism and insulin resistance also tend 
to have acanthosis nigricans[9,10]. Patients with HAIR-AN syndrome may present with amenorrhea and 
signs of verilization[2,4]. They may also have increased levels of insulin, testosterone, and 
androstenedione levels with normal andrenal function[3]. Adolescents with HAIR-AN syndrome usually 
present with normal levels of luteinizing hormone (LH) and follicle-stimulating hormone (FHS)[3], 
although the ratio of LH to FHS is usually more than one. There are no specific protocols for treatment of 
this syndrome. Current management usually involves oral contraceptive pills with or without an 
antiandrogen. Oral contraceptives may suppress the hypothalamic-pituitary-ovarian axis which would 
lower ovarian steroid production[3]. 
Metformin is an insulin-sensitizing drug that has also been used in the treatment of HAIR-AN 
syndrome. Few studies test its use in adolescents, but in small trials it appears to reduce weight gain and 
regulate menstrual cycles. The effect of metformin on hirsutism has not been adequately studied[11]. The 
reduction of insulin resistance by metformin could reduce the appearance of acanthosis nigricans on the 
adolescent[12]. Previous studies have shown that metformin reduces the body mass index (BMI) of 
HAIR-AN patients and also helps regulate the menstrual cycle[13]. Use of cosmetic methods such as laser 
hair removal can also be utilized to reduce the severity of existing hirsutism[11]. Weight loss is also an 
effective way to reduce the manifestations of HAIR-AN syndrome and also reduce the risk for other 
diseases including diabetes and heart disease. A lower-calorie diet rich in fiber and protein can aid in 
healthy weight loss for the obese adolescent[6]. It is also recommended that physicians council the 
adolescent about the importance of exercise and assist in the formation of an exercise program tailored to 
the individual patient. 
Beyond physical treatment of HAIR-AN syndrome, physicians should also be observant of the mental 
state of the patient. Most adolescent females are concerned with their body image and are sensitive to the 
phenotypic manifestations of the syndrome[11]. A short evaluation of the patient’s concerns and emotions 
associated with the diagnosis of HAIR-AN syndrome can alert physicians to any problems. Reassurance 
and thorough explanations of the treatment can comfort and encourage the patient. 
In this study, we reviewed clinical data from patients attending the Adolescent Medicine Clinic at the 
University Based Health Center to investigate the occurrence. 
METHODS 
Retrospective review of medical records attending the Adolescent Medicine Clinic at the University 
Based Health Center in a medium-sized city was performed to assess the occurrence, clinical profiles, and 
management issues of patients with HAIR-AN syndrome. The study was approved with an exemption 
protocol from the Institutional Review Board at the University of Kentucky, Lexington.  
RESULTS 
In the period between January 2000 and December 2002, a total of 1,002 young women between the ages 
of 10 and 21 years attended the Adolescent Medicine Clinic at the University Based Health Center. This 
number included all visits regardless of the reason for attending the clinic, including health maintenance, 
acute care, or family planning. A total of 136 patients (13.6%) presented with complaints of irregular 
menstrual periods; 50 patients (5% of the total and 36.8% of those with irregular periods) were diagnosed 
with HAIR-IN syndrome. Patients were diagnosed with HAIR-AN syndrome if they had clinical 
characteristics indicating hyperandrogenism, insulin resistance, and acanthosis nigricans[14]. 
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Demographic characteristics of the patients are shown in Table 1. All 50 patients had laboratory evidence 
of insulin resistance (elevated insulin level) and most patients had one or more laboratory values 
indicative of hyperandrogenism[1,2,3,4,5,6,7,14]; 74% of the patients had at least one comorbidity 
(Tables 1 and 2).  
TABLE 1 
Demographic and Clinical Profiles of Patients 
Age range 
given as 10-
21 
elsewhere. 
Age (Mean + SD} 15.5 ± 2.7 Years, 10–19 
Race 20 (40%) W, 27 (54%) B, 3 (6%) Other 
Menarche 10.8 ± 1.3 Years of age 
Initial weight 94.5 ± kg (208.9 ± 44.6 lb) 
Initial BMI 33.1 ± 4.1 kg/m2
Previous pregnancy 3 (6%) Yes, 47 (94%) No 
Current sexual activity 15 (30%) Yes, 35 (70%) No 
Comorbidity 37 (74%) Yes, 13 (26%) No 
Insurance 28 (56%) MC, 18 (36%) Private, 4(8%) None 
TABLE 2 
Most Common Comorbidity 
Depression 12 (24%) 
Bipolar disorder 2 (4%) 
Learning disability 1 (2%) 
Recurrent headaches 17 (34%) 
Allergies 22 (44%) 
Hypertension 4 (8%) 
GERD 4 (8%) 
Diabetes (Type II) 8 (16%) 
Once the diagnosis was made, patients were treated by a team consisting of an adolescent medicine 
physician, nutritionist, social worker, and psychologist. Treatment included nutrition changes and a 
physical activity regimen with the goal of maintaining, then reducing, body weight. Patients were also 
started on periodic psychology counseling to improve self-esteem and to address any mental health issues. 
All patients were started on monophasic, low androgenic, oral contraceptive pills, usually 
norgestimate/ethinyl estradiol or drospirenone/ethinyl estradiol. Forty patients (80%) who had fasting 
glucose to insulin ratio of less than five were also started on metformin (Bristol-Myers Squibb, Princeton, 
NJ) or generic equivalent. Patients were usually started on a dose of 500 mg once a day for 1 week, then 
the dose was gradually increased to a maximum of 100 mg twice a day depending on tolerance of the 
patient to the medication. All patients had a metabolic screen and liver function test performed prior to 
starting metformin and every 6 months thereafter.  
Evaluation of patients every 3 months showed that 80% of the patients were compliant with all 
aspects of treatment throughout the follow-up period and 20% of the patients had no compliance issues 
either with the physical activity/nutrition plan or with taking their oral contraceptive pills. Interestingly, 
all patients were compliant with the psychological counseling for the allotted 6 months of treatment. All 
patients that were compliant with oral contraceptive pills had regular menstrual periods following 
treatment and their acne and/or hirsutism improved or were unchanged after treatment, 20% of the 
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patients had improvement in their acanthosis nigricans, while the others were unchanged. Of the patients 
on metformin, 40% reported nausea, but no other side effects were reported and none had a problem with 
liver function at follow-up. Only 1 patient out of the 40 (2.5%) using metformin discontinued use because 
of nausea.  
DISCUSSION 
Most adolescent females are usually concerned about their body image and are very sensitive to any 
changes that may interfere with their appearance[11]. The symptoms of HAIR-AN syndrome do exactly 
that, by increasing the severity of acne, by inducing hirsutism and the appearance of acanthosis nigricans, 
in addition to obesity[2,3,4,5,6]. In addition to the appearance issues there are also significant medical 
consequences such as irregular periods, infertility, and type II diabetes[2,3,4,5,6]. Early detection, 
diagnosis, and treatment of HAIR-AN syndrome may reduce the symptoms and improve the quality of 
life of these young women. Based on the results of this study, HAIR-AN syndrome appears to be a fairly 
common disorder in adolescents with 5% of the clinic female adolescent population suffering from the 
disease. This number is somewhat higher than what is reported in other studies[9,10]. In part, this may be 
due to the fact that our clinic is a tertiary care center and attended by patients with more morbidity 
referred by their primary care providers. Nevertheless, this syndrome constitutes significant problems for 
young women.  
In this study, 30% of the patients with HAIR-AN syndrome also had a mental health comorbidity, 
most frequently depression, in 24% of the patients (Table 2); 70% of the patients in this study were not 
sexually active, which is different than their peer groups in our area, where 68% of the 16 year olds have 
had at least one sexual experience (unpublished observation). In general, adolescents are notoriously 
noncompliant with long-term treatment. In this study, however, 80% of the patients were compliant with 
treatment, which may be due to the multidisciplinary approach to the patient in our clinic in addition to 
the desire to improve their appearance and self-esteem.  
The finding that metformin was well tolerated in this patient population may help future long-term 
prospective studies on the subject. In most patients, there was significant success of treatment both in 
terms of appearance and actual improvement in regulating their menstrual periods, improving their BMI, 
and preventing the development of type II diabetes and other severe medical consequences.  
Our study is limited by the retrospective nature and the relatively small number of participants. 
CONCLUSION 
HAIR-AN syndrome is a common multisystem disorder in the adolescent age group, which is associated 
with significant morbidity and self-esteem issues. Early detection, diagnosis, and treatment can help 
reduce further morbidity, improve self-esteem, and have a positive impact on the quality of life of these 
patients. 
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